<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
<PublisherName>OICC Press</PublisherName>
<JournalTitle>Journal of Nanostructure in Chemistry</JournalTitle>
<Issn>2193-8865</Issn>
<Volume>16</Volume>
<Issue>3</Issue>
<PubDate PubStatus="epublish">
<Year>2026</Year>
<Month>06</Month>
<Day>30</Day>
</PubDate>
</Journal>
<ArticleTitle>Viscoelastic Janus Nanohydrogels for IL-1β Binding: Synthesis, Structure, and Release Kinetics</ArticleTitle>
<VernacularTitle></VernacularTitle>
<FirstPage></FirstPage>
<LastPage></LastPage>
<ELocationID EIdType="doi">10.57647/jnsc.2026.1603.14</ELocationID>
<Language>EN</Language>
<AuthorList>
<Author>
<FirstName>Lingyan</FirstName>
<LastName>Peng</LastName>
<Affiliation>Department of Periodontology, Peking University School and Hospital of Stomatology &amp; National Center for Stomatology &amp; National Clinical Research Center for Oral Diseases &amp; National Engineering Research Center of Oral Biomaterials and Digital Medical Devices, Beijing, 100081, China</Affiliation>
<Identifier Source="ORCID"></Identifier>
</Author>
<Author>
<FirstName>Guohong</FirstName>
<LastName>Yuan</LastName>
<Affiliation>National Research Institute for Family Planning National Human Genetic Resources Center</Affiliation>
<Identifier Source="ORCID"></Identifier>
</Author>
<Author>
<FirstName>Guanghao</FirstName>
<LastName>Wu</LastName>
<Affiliation>School of Medical Technology, Beijing Institute of Technology, Beijing, 100081, China</Affiliation>
<Identifier Source="ORCID"></Identifier>
</Author>
<Author>
<FirstName>Xiaohui</FirstName>
<LastName>Yin</LastName>
<Affiliation>First Clinical Division, Peking University School and Hospital of Stomatology &amp; National Center for Stomatology &amp; National Clinical Research Center for Oral Diseases &amp; National Engineering Research Center of Oral Biomaterials and Digital Medical Devices, Beijing, 100034, China</Affiliation>
<Identifier Source="ORCID"></Identifier>
</Author>
<Author>
<FirstName>Yong</FirstName>
<LastName>Zhang</LastName>
<Affiliation>First Clinical Division, Peking University School and Hospital of Stomatology &amp; National Center for Stomatology &amp; National Clinical Research Center for Oral Diseases &amp; National Engineering Research Center of Oral Biomaterials and Digital Medical Devices, Beijing, 100034, China</Affiliation>
<Identifier Source="ORCID"></Identifier>
</Author>
<Author>
<FirstName>Xiangying</FirstName>
<LastName>Ouyang</LastName>
<Affiliation>Department of Periodontology, Peking University School and Hospital of Stomatology &amp; National Center for Stomatology &amp; National Clinical Research Center for Oral Diseases &amp; National Engineering Research Center of Oral Biomaterials and Digital Medical Devices, Beijing, 100081, China</Affiliation>
<Identifier Source="ORCID"></Identifier>
</Author>
<Author>
<FirstName>Jing</FirstName>
<LastName></LastName>
<Affiliation>First Clinical Division, Peking University School and Hospital of Stomatology &amp; National Center for Stomatology &amp; National Clinical Research Center for Oral Diseases &amp; National Engineering Research Center of Oral Biomaterials and Digital Medical Devices, Beijing, 100034, China</Affiliation>
<Identifier Source="ORCID"></Identifier>
</Author>
</AuthorList>
<PublicationType>Journal Article</PublicationType>
<History>
<PubDate PubStatus="received">
<Year>2026</Year>
<Month>06</Month>
<Day>30</Day>
</PubDate>
</History>
<Abstract>Interleukin-1β (IL-1β) is a potent pro-inflammatory cytokine central to the pathogenesis of numerous autoinflammatory and chronic inflammatory diseases. Current systemic anti-IL-1β therapies, while effective, are associated with significant side effects, necessitating the development of materials for localized immunomodulation. This study reports the design, synthesis, and comprehensive characterization of a novel, dual-function Viscoelastic Janus Nanohydrogel (VJNH) platform for the simultaneous sequestration of IL-1β and controlled release of an anti-inflammatory therapeutic. VJNHs were synthesized with an asymmetric Au@SiO₂ inorganic core; the gold (Au) face was functionalized with a high-affinity DNA aptamer for IL-1β capture, while the silica (SiO₂) face served as an anchor for a viscoelastic hydrogel shell. This shell was formed via dynamic Schiff base (C=N) chemistry between aldehyde-functionalized hyaluronic acid (oHA) and amine-rich gelatin. Transmission electron microscopy (TEM) and X-ray photoelectron spectroscopy (XPS) confirmed the asymmetric Janus morphology and spatially segregated surface chemistry. Rheological analysis demonstrated the ECM-mimetic viscoelastic properties of the network, including high solid-like character (G' &amp;gt; G'') and rapid stress relaxation (relaxation time τ ≈ 120 s), attributed to the dynamic covalent linkages. A comparative study identified an optimal VJNH-2 (1:1 oHA:Gelatin) formulation, which exhibited superior IL-1β binding capacity (≈ 180 ng/mg). Surface plasmon resonance (SPR) analysis revealed high-affinity and specific binding, with an equilibrium dissociation constant (Kₙ) of 1.24 nM. Concurrently, the VJNHs demonstrated sustained, pH-responsive release of a model drug (Dexamethasone), fitting a Fickian diffusion mechanism (Higuchi and Korsmeyer-Peppas models). All VJNH formulations were non-cytotoxic to L929 fibroblasts. These results establish VJNHs as a sophisticated "sense-and-respond" platform, synergizing spatial, mechanical, and chemical functionalities for advanced, localized treatment of inflammatory disorders.</Abstract>
<ObjectList>
<Object Type="keyword">
<Param Name="value">Aptamer</Param>
</Object>
<Object Type="keyword">
<Param Name="value">Dexamethasone</Param>
</Object>
<Object Type="keyword">
<Param Name="value">Immunomodulation</Param>
</Object>
<Object Type="keyword">
<Param Name="value">Periodontitis</Param>
</Object>
<Object Type="keyword">
<Param Name="value">Schiff Base</Param>
</Object>
</ObjectList>
</Article>
</ArticleSet>